• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

Stanford University — Coronavirus Drug Research (February 2020) (Jeffrey Glenn)

Visit Grantee Site
  • Focus Area: Scientific Research
  • Organization Name: Stanford University
  • Amount: $165,000

  • Award Date: February 2020

Table of Contents


    Grant investigators: Chris Somerville and Heather Youngs

    This page was reviewed but not written by the grant investigators. Stanford University staff also reviewed this page prior to publication.


    Open Philanthropy recommended an unrestricted grant of $165,000 to Stanford University to support work led by Stanford Professors Jeffrey Glenn and Rhiju Das and University of North Carolina Professor Ralph Baric, which they intend to use to test antiviral drug candidates against the COVID-19 coronavirus.

    This falls within our work on scientific research, and specifically within our interest in science supporting biosecurity and pandemic preparedness.

    Related Items

    • Scientific Research

      Stanford University — Pandemic Preparedness Center

      Open Philanthropy recommended a grant of $200,000 to Stanford University to support the university’s new Pandemic Preparedness Center led by Professor Jeffrey Glenn. This falls within our focus area...

      Read more
    • Scientific Research

      Stanford University — Immunization Research

      Open Philanthropy recommended a grant of $350,000 to Stanford University to support research led by Professor Michael Fischbach on a novel immunization method. Professor Fischbach recently discovered that exposing mice...

      Read more
    • Scientific Research

      Stanford University — Research on Science and Innovation (Heidi Williams)

      Open Philanthropy recommended a grant of $600,823 to Stanford University to support a one-year period of research leave for Professor Heidi Williams. During this time, Professor Williams will pursue research...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!